Free Trial

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.08 +0.01 (+15.38%)
(As of 11/12/2024 ET)

LABS vs. TGOD, NINE, WMD, SUGR, MDP, VIR, ZOM, IN, META, and DB

Should you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), WeedMD (WMD), SugarBud Craft Growers (SUGR), Medexus Pharmaceuticals (MDP), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), Meta Growth (META), and Decibel Cannabis (DB). These companies are all part of the "drug manufacturers - specialty & generic" industry.

MediPharm Labs vs.

MediPharm Labs (TSE:LABS) and Green Organic Dutchman (TSE:TGOD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, community ranking, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

0.7% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Green Organic Dutchman received 154 more outperform votes than MediPharm Labs when rated by MarketBeat users. Likewise, 85.65% of users gave Green Organic Dutchman an outperform vote while only 65.79% of users gave MediPharm Labs an outperform vote.

CompanyUnderperformOutperform
MediPharm LabsOutperform Votes
25
65.79%
Underperform Votes
13
34.21%
Green Organic DutchmanOutperform Votes
179
85.65%
Underperform Votes
30
14.35%

MediPharm Labs has higher revenue and earnings than Green Organic Dutchman. MediPharm Labs is trading at a lower price-to-earnings ratio than Green Organic Dutchman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$37.76M0.82-C$13.31M-C$0.04-1.88
Green Organic DutchmanC$31.37M0.00-C$137.58M-C$0.26N/A

In the previous week, MediPharm Labs' average media sentiment score of 0.00 equaled Green Organic Dutchman'saverage media sentiment score.

Company Overall Sentiment
MediPharm Labs Neutral
Green Organic Dutchman Neutral

Green Organic Dutchman has a net margin of 0.00% compared to MediPharm Labs' net margin of -35.25%. Green Organic Dutchman's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-35.25% -24.96% -7.17%
Green Organic Dutchman N/A N/A N/A

Summary

Green Organic Dutchman beats MediPharm Labs on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

LABS vs. The Competition

MetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$30.83MC$1.14BC$5.23BC$5.81B
Dividend YieldN/A3.13%4.69%5.30%
P/E Ratio-1.88104.23123.7926.14
Price / Sales0.823,238.831,379.341,545.22
Price / Cash1.3010.3539.4876.47
Price / Book0.633.256.223.12
Net Income-C$13.31MC$148.11MC$118.51MC$290.91M
7 Day PerformanceN/A-2.01%1.01%-0.54%
1 Month PerformanceN/A-3.83%6.71%0.48%
1 Year PerformanceN/A95.41%42.96%42.85%

MediPharm Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.08
+15.4%
N/A+7.1%C$30.83MC$37.76M-1.88130High Trading Volume
TGOD
Green Organic Dutchman
N/AC$0.17
-2.9%
N/AN/AC$89.95MC$31.37M-0.6541Gap Up
High Trading Volume
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%
N/A+0.0%C$89.36MC$12.87M19.07940Gap Up
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up
SUGR
SugarBud Craft Growers
N/AC$9.10
+1.1%
N/A+8,354.5%C$62.06MC$575.64M10.9644Gap Up
MDP
Medexus Pharmaceuticals
2.7981 of 5 stars
C$2.07
-4.6%
N/A+5.9%C$50.78MC$108.78M41.4098Analyst Revision
Gap Up
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down
IN
InMed Pharmaceuticals
N/AC$4.19
-1.6%
N/AN/AC$33.73MC$574,677.00-2.7712
META
Meta Growth
N/AC$0.14
flat
N/A+0.0%C$33.14MC$60.96M-0.6686,500Gap Down
DB
Decibel Cannabis
2.2365 of 5 stars
C$0.08
+7.1%
N/A-40.7%C$30.68MC$105.60M-7.5083,000Gap Up

Related Companies and Tools


This page (TSE:LABS) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners